ARDMORE, OK-- Statistics show people with diabetes have a 65% greater risk of developing Alzheimer's. Now, the same insulin used for diabetics could be used to help treat Alzheimer's patients. Amanda Brown has more on what this study could mean for people in our area
A recent pilot study in the Journal Archives of Neurology has suggested that inhaling insulin could play a part in helping individuals improve memory and even reverse symptoms of memory loss. Pharmacist Rebecca Reed said the research is still underway, but if the insulin does prove to work, it would be great news to Oklahoma because of the large community of diabetics. She said that a lot of diabetics do not know they are at great risk to the Alzheimer's disease and that it is just one of the possible complications that diabetes can bring.
"If you don't take care of yourself then your going to have more problems and complications and this is just one of the complications," she said.
Ann O'Conner was diagnosed with type two diabetes two years ago and said she is well aware of the complications it could produce. The recent study is good news to O'Conner, she said diabetes runs her family and her current roommate suffers from dementia.
"I see her just going downhill everyday you know and its heartbreaking," she said.
O'Connor said she is at ease knowing there is research being done to tackle memory loss, because if she is diagnosed with Alzheimer's, at least there's a chance they have found something that would help.
Weight loss surgery “is costly and does have treatment risks,” but studies in adults have found that it has long-term health benefits.
Sleep apnea device allows normal breathing, reduces stress on body, study suggests
Lack of awareness was most common reason cited for not having a living will
Research suggests CT scan screening might lead to needless worry, treatment in these cases
Finding may gain significance as legalization spreads across U.S., study author says
WASHINGTON (AP) — It's that time of year again: doctors caring for Medicare patients once more face a steep pay cut. But this time Congress is pursuing a permanent fix to the annual drama that has undermined the medical profession's confidence in the nation's premier health program.
By Malena Castaldi and Felipe Llambias MONTEVIDEO (Reuters) - Uruguay became the first country to legalize the growing, sale and smoking of marijuana on Tuesday, a pioneering social experiment that will be closely watched by other nations debating drug liberalization. A government-sponsored bill approved by 16-13 votes in the Senate provides for regulation of the cultivation, distribution and consumption of marijuana and is aimed at wresting the business from criminals in the small South American nation. Backers of the law, some smoking joints, gathered near Congress holding green balloons, Jamaican flags in homage to Bob Marley and a sign saying: "Cultivating freedom, Uruguay grows." Cannabis consumers will be able to buy a maximum of 40 grams (1.4 ounces) each month from licensed pharmacies as long as they are Uruguayan residents over the age of 18 and registered on a government database that will monitor their monthly purchases. When the law is implemented in 120 days, Uruguayans will be able to grow six marijuana plants in their homes a year, or as much as 480 grams (about 17 ounces), and form smoking clubs of 15 to 45 members that can grow up to 99 plants per year.